We are live on ! Find out more
TSW

Thompson Siegel & Walmsley Portfolio holdings

AUM $5.7B
1-Year Est. Return 6.69%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+6.69%
3 Year Est. Return
+28.78%
5 Year Est. Return
+35.85%
10 Year Est. Return
+92.81%
AUM
$7.3B
AUM Growth
+$297M
Cap. Flow
-$50.3M
Cap. Flow %
-0.69%
Top 10 Hldgs %
17.43%
Holding
817
New
58
Increased
143
Reduced
218
Closed
72

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$86.7M
2
GPK icon
Graphic Packaging
GPK
+$49.8M
3
FLEX icon
Flex
FLEX
+$46.9M
4
ORI icon
Old Republic International
ORI
+$46M
5
NVR icon
NVR
NVR
+$40.7M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.1M
2
BG icon
Bunge Global
BG
+$50.3M
3
LDOS icon
Leidos
LDOS
+$39.3M
4
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$38.5M
5
VYX icon
NCR Voyix
VYX
+$34.8M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Technology 12.23%
3 Healthcare 9.96%
4 Consumer Discretionary 9.73%
5 Utilities 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MAS icon
526
Masco
MAS
$14.1B
$38K ﹤0.01%
641
– –
FUL icon
527
H.B. Fuller
FUL
$2.97B
$37K ﹤0.01%
580
– –
O icon
528
Realty Income
O
$59.6B
$37K ﹤0.01%
567
– –
OUT icon
529
Outfront Media
OUT
$5.61B
$37K ﹤0.01%
1,575
– –
DFS
530
DELISTED
Discover Financial Services
DFS
$36K ﹤0.01%
306
-10
-3% -$1.13K
FN icon
531
Fabrinet
FN
$15.6B
$36K ﹤0.01%
375
– –
MSI icon
532
Motorola Solutions
MSI
$72.3B
$36K ﹤0.01%
167
– –
SBH icon
533
Sally Beauty Holdings
SBH
$1.43B
$36K ﹤0.01%
1,650
– –
SBUX icon
534
Starbucks
SBUX
$120B
$36K ﹤0.01%
319
– –
TRV icon
535
Travelers Companies
TRV
$78.1B
$36K ﹤0.01%
242
– –
HLX icon
536
Helix Energy Solutions
HLX
$1.4B
$35K ﹤0.01%
6,050
– –
AZN icon
537
AstraZeneca
AZN
$263B
$34K ﹤0.01%
284
– –
ENDP
538
DELISTED
Endo International plc
ENDP
$34K ﹤0.01%
7,200
– –
MUSA icon
539
Murphy USA
MUSA
$11.2B
$33K ﹤0.01%
246
-451
-65% -$62.3K
WNC icon
540
Wabash National
WNC
$512M
$33K ﹤0.01%
2,070
– –
TBRG
541
DELISTED
TruBridge
TBRG
$33K ﹤0.01%
1,000
+400
+67% +$12.7K
HR
542
DELISTED
Healthcare Realty Trust Incorporated
HR
$33K ﹤0.01%
1,086
– –
AVNT icon
543
Avient
AVNT
$3.33B
$32K ﹤0.01%
650
– –
ENS icon
544
EnerSys
ENS
$6.78B
$32K ﹤0.01%
325
– –
EBIX
545
DELISTED
Ebix Inc
EBIX
$32K ﹤0.01%
930
– –
HY icon
546
Hyster-Yale Materials Handling
HY
$599M
$31K ﹤0.01%
425
– –
IIIN icon
547
Insteel Industries
IIIN
$593M
$31K ﹤0.01%
950
– –
ACIW icon
548
ACI Worldwide
ACIW
$5.83B
$30K ﹤0.01%
810
-13
-2% -$508
LPX icon
549
Louisiana-Pacific
LPX
$5.06B
$30K ﹤0.01%
500
– –
MNRO icon
550
Monro
MNRO
$383M
$30K ﹤0.01%
475
– –
20 21
22
23 24

Similar funds

PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return

Thompson Siegel & Walmsley's Q2 2021 Portfolio in Review

As of Q2 2021, Thompson Siegel & Walmsley held 817 positions worth $7.3B, up 4.2% from $7.01B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Thompson Siegel & Walmsley's Q2 2021 filing shows 58 new, 143 increased, 218 reduced and 72 closed positions. Its largest new stake was Organon & Co: 2,634,306 shares worth $79.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Thompson Siegel & Walmsley's largest Q2 2021 buy was Organon & Co: 2,634,306 shares worth $79.7M.
  • Thompson Siegel & Walmsley added most to Graphic Packaging in Q2 2021, an estimated $49.8M increase.
  • Thompson Siegel & Walmsley's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $92.1M.
  • Thompson Siegel & Walmsley fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $38.5M.
  • Thompson Siegel & Walmsley's ten largest holdings make up 17% of its $7.3B portfolio in Q2 2021.
  • Thompson Siegel & Walmsley opened 58 new positions and closed 72 in Q2 2021.
  • Thompson Siegel & Walmsley's portfolio value rose 4.2% quarter-over-quarter to $7.3B.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2021, filed 9 Aug 2021.